Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus
Mycobacterium abscessus (Mab) is one of the most drug resistant bacteria with a high treatment failure rate. Antimicrobial peptides (AMPs) are alternative therapeutic agents against this infection. This study was aimed to assess the in vitro activities of thirteen AMPs (S5, S52, S6, S61, S62, S63, K...
Guardado en:
Autores principales: | Phantitra Sudadech, Sittiruk Roytrakul, Orawee Kaewprasert, Auttawit Sirichoat, Ploenchan Chetchotisakd, Sakawrat Kanthawong, Kiatichai Faksri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/063d36d245df467ebbe56aea267830bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus.
por: Phantitra Sudadech, et al.
Publicado: (2021) -
Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline.
por: Jaryd R Sullivan, et al.
Publicado: (2021) -
The Prophage and Plasmid Mobilome as a Likely Driver of Mycobacterium abscessus Diversity
por: Rebekah M. Dedrick, et al.
Publicado: (2021) -
RETROSPECTIVE ANALYSIS OF SLOVENIAN MYCOBACTERIUM AVIUM COMPLEX AND MYCOBACTERIUM ABSCESSUS COMPLEX ISOLATES AND MOLECULAR RESISTANCE PROFILE
por: S. Truden, et al.
Publicado: (2018) -
Genomic characterization of sporadic isolates of the dominant clone of Mycobacterium abscessus subspecies massiliense
por: Rebecca M. Davidson, et al.
Publicado: (2021)